Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells. (August 2017)
- Record Type:
- Journal Article
- Title:
- Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells. (August 2017)
- Main Title:
- Pentablock copolymer dexamethasone nanoformulations elevate MYOC: in vitro liberation, activity and safety in human trabecular meshwork cells
- Authors:
- Agrahari, Vibhuti
Li, Guorong
Agrahari, Vivek
Navarro, Iris
Perkumas, Kristin
Mandal, Abhirup
Stamer, W Daniel
Mitra, Ashim K - Abstract:
- Aim: The aim of this study is to examine the elevation of MYOC in long-term treatment of human trabecular meshwork (HTM) cells using dexamethasone (DEX) encapsulated pentablock (PB) copolymer-based nanoparticles (NPs) (DEX-PB-NPs).Materials & methods: PB copolymers and DEX-PB-NPs were synthesized and characterized using nuclear magnetic resonance, gel permeation chromatography, and X-ray diffraction analyses. MYOC levels secreted from HTM cells were measured by western blot (WB) analysis.Results: DEX-PB-NPs were formulated in the size range of 109 ± 3.77 nm (n = 3). A long term DEX release from the NPs was observed over three months. Cell viability and cytotoxicity were not affected up to 12 weeks of treatment with PB-copolymer or DEX-PB-NPs. WB data from five HTM cell strains showed that MYOC levels increased by 5.2 ± 1.3, 7.4 ± 4.3, and 2.8 ± 1.1-fold in the presence of DEX-PB-NPs compared with 9.2 ± 3.8, 2.2 ± 0.5, and 1.5 ± 0.3-fold at 4, 8 and 12 weeks in control-DEX treatment group, respectively (n = 5). Based on the decline in MYOC levels after withdrawal of DEX from control wells, DEX-PB-NPs released the DEX for at least 10 weeks.Conclusion: The treatment of HTM cells using DEX-PB-NPs were analyzed in this study. The in vitro cell-based system developed here is a valuable tool for determining the safety and effects of steroids released from polymeric NPs.
- Is Part Of:
- Nanomedicine. Volume 12:Number 16(2017)
- Journal:
- Nanomedicine
- Issue:
- Volume 12:Number 16(2017)
- Issue Display:
- Volume 12, Issue 16 (2017)
- Year:
- 2017
- Volume:
- 12
- Issue:
- 16
- Issue Sort Value:
- 2017-0012-0016-0000
- Page Start:
- 1911
- Page End:
- 1926
- Publication Date:
- 2017-08
- Subjects:
- block copolymer -- MYOC -- nanoparticle -- steroids -- sustained release -- trabecular meshwork cells -- western blot
Nanotechnology -- Periodicals
Medical technology -- Periodicals
Nanotechnology -- Therapeutic use -- Periodicals
610.28 - Journal URLs:
- http://www.futuremedicine.com/loi/nnm ↗
http://www.futuremedicine.com/ ↗ - DOI:
- 10.2217/nnm-2017-0140 ↗
- Languages:
- English
- ISSNs:
- 1743-5889
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9830.015000
British Library DSC - BLDSS-3PM
British Library HMNTS - Digital store
British Library HMNTS - ELD Digital store - Ingest File:
- 22017.xml